Evidence map›Paper›PMID 35044445›Full record

ArticleTranslational vision science & technology2022

Archetypal Analysis Reveals Quantifiable Patterns of Visual Field Loss in Optic Neuritis.

Elena Solli, Hiten Doshi, Tobias Elze, Louis Pasquale, Michael Wall, Mark Kupersmith

Open access · goldAbstract read
In one paragraph

Article in Translational vision science & technology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Interpretation of the Visual Field in Neuro-ophthalmic Disorders.Current neurology and neuroscience reports · 2024
    Review
  11. Visualising structural and functional characteristics distinguishing between newly diagnosed high-tension and low-tension glaucoma patients.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Elena SolliDeptartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Hiten DoshiAlbert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA.
Tobias ElzeSchepens Eye Research Institute, Harvard Medical School, Boston, MA, USA.
Louis PasqualeDepartment of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Michael WallDepartments of Neurology and Ophthalmology and Visual Sciences, University of Iowa, Iowa City, Iowa, USA.
Mark KupersmithDeptartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Icahn School of Medicine at Mount Sinai · USMontefiore Medical Center · USSmith-Kettlewell Eye Research Institute · USUniversity of Iowa · US

Funding

VISION RESEARCHP30EY003790 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI Patricia Ann D'Amore · 1985 to 2026
$25.5M
Gene-Environment Interactions in GlaucomaR01EY015473 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI PASQUALE, LOUIS ROBERT · 2005 to 2021
$8.3M
Statistical Unsupervised Learning VF for IIHTT & ONTTR21EY032522 · NEI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KUPERSMITH, MARK J · 2021 to 2022
$495k
NEI NIH HHS P30 EY003790NEI NIH HHS R01 EY015473NEI NIH HHS R21 EY032522
6 · The paper itself

Abstract

Purpose: Identifying and monitoring visual field (VF) defects due to optic neuritis (ON) relies on qualitative clinician interpretation. Archetypal analysis (AA), a form of unsupervised machine learning, is used to quantify VF defects in glaucoma. We hypothesized that AA can identify quantifiable, ON-specific patterns (as archetypes [ATs]) of VF loss that resemble known ON VF defects. Methods: We applied AA to a dataset of 3892 VFs prospectively collected from 456 eyes in the Optic Neuritis Treatment Trial (ONTT), and decomposed each VF into component ATs (total weight = 100%). AA of 568 VFs from 61 control eyes was used to define a minimum meaningful (≤7%) AT weight and weight change. We correlated baseline ON AT weights with global VF indices, visual acuity, and contrast sensitivity. For eyes with a dominant AT (weight ≥50%), we compared the ONTT VF classification with the AT pattern. Results: AA generated a set of 16 ATs containing patterns seen in the ONTT. These were distinct from control ATs. Baseline study eye VFs were decomposed into 2.9 ± 1.5 ATs. AT2, a global dysfunction pattern, had the highest mean weight at baseline (36%; 95% confidence interval, 33%-40%), and showed the strongest correlation with MD (r = -0.91; P < 0.001), visual acuity (r = 0.70; P < 0.001), and contrast sensitivity (r = -0.77; P < 0.001). Of 191 baseline VFs with a dominant AT, 81% matched the descriptive classifications. Conclusions: AA identifies and quantifies archetypal, ON-specific patterns of VF loss. Translational Relevance: AA is a quantitative, objective method for demonstrating and monitoring change in regional VF deficits in ON.

Indexed as

Optic NeuritisVisual FieldsHumansRetrospective StudiesVision DisordersVisual Field Tests

Identifiers

PMID35044445
PMCPMC8787544
OpenAlexW4205173253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.